Litcius/Paper detail

Low dose intravenous cangrelor versus glycoprotein IIb/IIIa inhibitors in endovascular treatment of tandem lesions

Mouhammad Jumaa, Aarón Rodríguez-Calienes, Giana Dawod, Juan Vivanco‐Suarez, Ameer E Hassan, Afshin A. Divani, Marion Oliver, Marc Ribó, Nils Petersen, Michael Abraham, Johanna T Fifi, Waldo R. Guerrero, Amer Malik, James E. Siegler, Thanh N. Nguyen, Sunil A. Sheth, Albert J. Yoo, Guillermo Linares, Nazli Janjua, Darko Quispe‐Orozco, Milagros Galecio‐Castillo, Cynthia Zevallos, Marco Málaga, Mudassir Farooqui, Tudor G. Jovin, Syed Zaidi, Santiago Ortega‐Gutiérrez

2023Journal of Stroke and Cerebrovascular Diseases18 citationsDOIOpen Access PDF

Topics & Concepts

CangrelorMedicineTirofibanEptifibatideInternal medicineOdds ratioRegimenIntraventricular hemorrhageGastroenterologyAnesthesiaMyocardial infarctionSurgeryPercutaneous coronary interventionP2Y12PregnancyBiologyGestational ageGeneticsCerebrovascular and Carotid Artery DiseasesPeripheral Artery Disease ManagementAntiplatelet Therapy and Cardiovascular Diseases